Editorial

Imbalance in Th Cell Polarization and its Relevance in Type 1 Diabetes Mellitus

Charles Sia

Keywords: type 1 diabetes, Th cell, polarization

Abstract

Functional polarization of T helper (Th) subsets of lymphocytes has been implicated in promoting or conferring risk to Type 1 diabetes mellitus (T1DM) development in human and diabetic animal models. It is assumed that an immoderate preponderance of type 1 immunity establishes the prerequisite for this development. Over the past years, various immune-intervention strategies have been tested to protect diabetic animals from developing overt diabetes. These protocols implicate a protective mechanism that is attributed to a change in the set of autoreactive Th cells from their Th1 to the Th2 phenotype. The studies were aimed at improving the effectiveness of Th2 cells to secrete the principal cytokines, IL-4 and IL-10, in order to mediate protection from diabetes in NOD mice. In contrast, some immune-modulation protocols utilizing non-specific reagents report that diabetes protection is apparently attributed to preferential survival of both Th1 and Th2 cells, rather than via a shift from their Th1 to Th2 phenotypes. Even though we know that excessive immune responses against self antigens are also controlled and terminated by regulatory T cells, this article focuses on the polarization of Th effector cells and discusses the controversial findings regarding the Th1/Th2 hypothesis to draw a conclusion on its relevance in T1DM from the existing knowledge.

Fulltext: HTML , PDF (299KB)

This article has been cited by other articles:

	Gene therapy in type 1 diabetes Bagley J, Paez-Cortez J, Tian C, Iacomini J Crit Rev Immunol 2008. 28(4):301-324
	The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes Mabley JG, Pacher P, Murthy KG, Williams W, Southan GJ, Salzman AL, Szabo C J Endocrinol 2008. 198(3):581-589
	Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production Bitan M, Weiss L, Zeira M, Reich S, Pappo O, Vlodavsky I, Slavin S Diabetes Metab Res Rev 2008. 24(5):413-421
	Feeding our immune system: impact on metabolism Wolowczuk I, Verwaerde C, Viltart O, Delanoye A, Delacre M, Pot B, Grangette C Clin Dev Immunol 2008. 2008:639803
	Improved efficacy of P277 fused to heat shock protein 65 of Mycobacterium tuberculosis against diabetes in nonobese diabetic mice Zhu A, Lu Y, Jin L, Wu J, Li T, Liu J Sheng Wu Gong Cheng Xue Bao (Chinese Journal of Biotechnology) 2008. 24(4):640-645
	Review of the literature: integrating psychoneuroimmunology into pediatric chronic illness interventions Nassau JH, Tien K, Fritz GK J Pediatr Psychol 2008. 33(2):195-207
	IL-10 gene modified dendritic cells inhibit T helper type 1-mediated alloimmune responses and promote immunological tolerance in diabetes Zhu H, Qiu W, Lei P, Zhou W, Wen X, He F, Li L, Dai H, Shen G, Gong F Cell Mol Immunol 2008. 5(1):41-46
	Effect of Displaying P277 Peptide on Surface of L-asparaginase on Its Antigenicity and Efficacy of Autoimmune Diabetes Prevention in NOD Mice Zhu AH, Liu WT, Long J, Wu J, Liu JJ, Li TM Chinese Journal of Biochemistry and Molecular Biology 2007. 23(9):730-737
	Expression and purification of peptide P277 and its primary pharmacology Zhu AH, Liu WT, Lu Y, Jin L, Wang Y, LIU JJ J Yangzhou Univ 2007. 28(4):13-17